Align succinyl-CoA-glutarate CoA-transferase (EC 2.8.3.13) (characterized)
to candidate H281DRAFT_01169 H281DRAFT_01169 Crotonobetainyl-CoA:carnitine CoA-transferase CaiB
Query= reanno::pseudo5_N2C3_1:AO356_10845 (406 letters) >lcl|FitnessBrowser__Burk376:H281DRAFT_01169 H281DRAFT_01169 Crotonobetainyl-CoA:carnitine CoA-transferase CaiB Length = 400 Score = 305 bits (781), Expect = 2e-87 Identities = 171/406 (42%), Positives = 229/406 (56%), Gaps = 18/406 (4%) Query: 1 MGALSHLRVLDLSRVLAGPWAGQILADLGADVIKVERPGNGDDTRAWGPPFLKDARGENT 60 M AL +RV+DLSRVL GP+ Q+LAD GA V+K+E P GD+TR WGPPF GE Sbjct: 1 MSALDTIRVVDLSRVLGGPFCTQMLADHGAQVVKIEPP-RGDETRGWGPPF----DGET- 54 Query: 61 TEAAYYLSANRNKQSVTIDFTRPEGQRLVRELAAKSDILIENFKVGGLAAYGLDYDSLKA 120 AAY+L NRNKQ + +D + + ++ +L A +D+L+ENF+ G + +GL Y L Sbjct: 55 --AAYFLGTNRNKQGMALDLGQSAARTVLLDLLADADVLVENFRAGTMEKWGLGYADLAQ 112 Query: 121 INPQLIYCSITGFGQTGPYAKRAGYDFMIQGLGGLMSLTGRPEGDEGAGPVKVGVALTDI 180 P+LIYC I+GFG TGP GYD + Q + GLMS+ G + G GP+++GV + DI Sbjct: 113 RFPRLIYCRISGFGSTGPLGGLPGYDAVAQAMSGLMSVNG----EAGGGPLRMGVPVIDI 168 Query: 181 LTGLYSTAAILAALAHRDHVGGGQHIDMALLDVQVACLANQAMNYLTTGNAPKRLGNAHP 240 +TG+ + AIL ALA R G GQ ++ L D ++ + NY TG + R GNAHP Sbjct: 169 VTGMNAAIAILLALAERTRSGKGQLVEATLYDSGLSLMHPHLPNYHLTGRSSPRTGNAHP 228 Query: 241 NIVPYQDFPTADGDFILTVGNDGQFRKFAEVAGQPQWADDPRFATNKVRVANRAVLIPLI 300 +I PY F TA L VGND QFR FA V G A DPRF N +R+A+R L I Sbjct: 229 SICPYDLFATASAPLFLAVGNDAQFRTFARVIGAEALATDPRFTNNALRLAHRDALREAI 288 Query: 301 RQATVFKTTAEWVTQLEQAGVPCGPINDLAQVFADPQVQARGLAMELPHLLAGKVPQVAS 360 A QL GVPCG ++D A P + RG+ + + G+ A+ Sbjct: 289 EAALAGLDGVSLAEQLMAEGVPCGVVSDTAGAACHPHTEHRGMTVRI-----GEYTGTAA 343 Query: 361 PIRLSETPVEYRNAPPLLGEHTLEVLQRVLGLDEAAVMAFREAGVL 406 P+ LS +P YR PP EHTLE+L R LG D+ + G + Sbjct: 344 PVTLSRSPPSYRRPPPKFAEHTLEIL-RSLGYDDERLATLTGTGAV 388 Lambda K H 0.319 0.137 0.408 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 500 Number of extensions: 22 Number of successful extensions: 5 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 406 Length of database: 400 Length adjustment: 31 Effective length of query: 375 Effective length of database: 369 Effective search space: 138375 Effective search space used: 138375 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory